Results

Total Results: 1,830 records

Showing results for "cost".

21. Long-Term Care for Older Adults: A Comparative Effectiveness Review of Institutional versus Home and Community-based Care | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/long-term-care-adults/research-protocol
    December 01, 2019 - Assessing the Cost of Care Assessing costs in the context of LTC requires attention to expenses associated … Meaningful cost comparisons between HCBS and institutional care must determine and specify the exact … Meanwhile, some cost analyses of HCBS include all public subsidies received by HCBS clients (e.g., rent … We will consider costs separately from the question of effectiveness; this review will not look at cost-effectiveness … Costs may include direct costs of care as well as costs such as resource utilization and family burden

22. Obesity (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - the highest potential for impact on clinical care, the health care system, patient outcomes, and costs … Finkelstein and colleagues (2009) estimated total annual U.S. medical costs associated with obesity … The online U.S. pharmacy-drug pricing resource, GoodRx, lists pricing for 30-day supplies ranging from … Qsymia pricing. [internet]. … Qsymia pricing information. [internet]. Santa Monica (CA): GoodRx, Inc.

23. Managed Care | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/managed-care?page=1
    March 10, 2014 - contracts with health care providers and medical facilities to provide care for members at reduced costs … Plans that restrict your choices usually cost you less. … If you want a flexible plan, it will probably cost more. … They still pay part of the cost if you go outside the network. … Measures in Health Research Protocol Archived October 24, 2013 Transitions of Care

24. Long-Term-Care-Adults Research-Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/long-term-care-adults_research-protocol.pdf
    December 20, 2011 - Assessing the Cost of Care Assessing costs in the context of LTC requires attention to expenses associated … Meaningful cost comparisons between HCBS and institutional care must determine and specify the exact … Meanwhile, some cost analyses of HCBS include all public subsidies received by HCBS clients (e.g., … cost-effectiveness. … Costs may include direct costs of care as well as costs such as resource utilization and family burden

25. Could the cost of additional staffing and techniques utilizing lesser restrictive interventions with pyschiatric patients provide an overall reduction of spending for institutions versus total spending with current use of seclusion and… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/could-the-cost-of-additional-staffing-and-techniques-utilizing-lesser-restrictive-interventions-with-pyschiatric-patients-provide-an-overall-reduction-of-spending-for-institutions-versus-total-spending-with-current-use-of-se
    November 01, 2017 - Home Evidence Reports Nominated Topics Could the cost … SHARE: Could the cost … Could the cost of additional staffing and techniques utilizing lesser restrictive interventions with … contribute to overall change in providing further evidence-based research that would indicate the overall cost … 2017 Page originally created August 2012 Internet Citation: Could the cost

26. Evidence-based Practice Center Systematic Review Protocol: Management of High-Need, High-Cost Patients: A Realist and Systematic Review (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mgmt-hnhc-patients-protocol.pdf
    November 07, 2019 - success in these models depends, in large part, on their effectiveness in addressing the care and costs … One direct approach is to identify the patients with the highest costs during a historical time period … care use/costs No increased risk for high health care use/costs Population: Identification of HNHC … patients (KQ 1 a-e) HNHC patients: High use/costs are preventable or modifiable High use/costs … ACOs at a crossroads: costs, risk and MACRA. A NAACOS policy white paper.

27. Cost effective long term care of the frail elderly | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/cost-effective-long-term-care-of-the-frail-elderly
    November 01, 2017 - Home Evidence Reports Nominated Topics Cost … elderly SHARE: Cost … Cost effective long term care of the frail elderly Does your question include a comparison of different … November 2017 Page originally created February 2011 Internet Citation: Cost … https://effectivehealthcare.ahrq.gov/get-involved/nominated-topics/cost-effective-long-term-care-of-the-frail-elderly

28. Defining an Optimal Format for Presenting Research Needs (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
    January 01, 2019 - parameterize models (nonsystematic review, systematic review, primary data, not stated); whether costs … proceed to calculate EVSI, the expected value of information from a sample n (and compare it to the costs … effectiveness plane scatter plot is a bivariate scatter plot of costs (measured in dollars in this … The interviewer proposed that operational definitions of feasibility and future research costs could … effectiveness analysis 2006 BMJ 18793033 Costs and effects of secondary prevention with perindopril

29. For patients with PKU, there is now a pharmaceutical drug to treat this condition. In the past is was treated by medical foods that eliminated the harmful substance phenylalanine. The cost of the new drug is $70K year. The cost to treat… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-t
    November 01, 2017 - The cost of the new drug is $70K year. … The cost of the new drug is $70K year. … The cost of the new drug is $70K year. … The cost of the two alternatives. … The cost of the new drug is $70K year. The cost to treat…. Content last reviewed November 2017.

30. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - Partial economic evaluations and other cost analyses or descriptions are out of scope as costs are … We will note whether cost analyses were reported. … analysis that did not relate cost to effectiveness. 3/17/20 Table 1, Outcomes INCLUDE: Process … Partial economic evaluations and other cost analyses or descriptions are out of scope as costs … The sentence on partial economic evaluations and other cost analyses was deleted based on the earlier

31. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/health-data-mapping/protocol
    March 01, 2021 - Partial economic evaluations and other cost analyses or descriptions are out of scope as costs are unable … We will note whether cost analyses were reported. … analysis that did not relate cost to effectiveness. 3/17/20 Table 1, Outcomes … Partial economic evaluations and other cost analyses or descriptions are out of scope as costs are unable … The sentence on partial economic evaluations and other cost analyses was deleted based on the earlier

32. Best Practices for Conducting Economic Evaluations in Health Care: A Systematic Review of Quality Assessment Tools (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/economic-evaluation-tools_research.pdf
    October 01, 2012 - " TX "cost analysis" TX "economic analysis" TX "Decision making" TX "health policy" TX reimbursement … Opportunity costs b. Charges c. Deflated charges (using cost-to-charge ratios) d. … Type and adequacy of comparisons* Costs 11. Cost perspective 12. Cost coverage 13. … Resources should be relevant to the perspective and described in natural units before a cost analysis … costs and effectiveness, and incremental cost effectiveness ratios 25.

33. Template for Draft Reports (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/long-term-care-adults-future_research.pdf
    July 01, 2013 - Evidence was also insufficient for cost comparisons. … Evidence was also insufficient for cost comparisons. … Need to make cost comparisons that account for LTC costs and all other relevant costs, including the … cost of room and board, costs of public subsidies (rent, transportation, and food stamps), cost of … and unobserved variables that may create a risk of bias Interest among researchers Duration Cost

34. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - The $294,000 annual cost of ivacaftor therapy was identified as a potentially controversial issue. … was set at about $294,000. 11 The manufacturer has implemented stratified pricing terms based on … patient insurance status and income. 12 While ivacaftor’s annual price is high, pricing was purported … The $294,000 annual cost of ivacaftor therapy was identified as a potentially controversial issue. … representing a health systems perspective estimated that treating all eligible patients with ivacaftor would cost

35. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - In October 2013, JAMA published an editorial (by O’Sullivan and colleagues) on orphan-drug pricing, … indicating that pricing models are unsustainable and using Kalydeco as an example. … for a monthly supply.11 The manufacturer has implemented 3 stratified pricing that is based … Although the cost of azithromycin therapy would be added to current treatment costs, its low cost and … Pricing for orphan drugs: will the market bear what society cannot?

36. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - pharmacies.10 The manufacturer has implemented stratified pricing that is based on patient insurance … Although the cost of azithromycin therapy would be additive to current treatment costs, its low cost … perhaps even cost-saving impact. 8 References 1. … Kalydeco pricing. [internet]. Santa Monica (CA): GoodRx, Inc. [accessed 2013 Jun 12]. [5 p]. … Azithromycin pricing. [internet]. Santa Monica (CA): GoodRx, Inc. [accessed 2013 Jun 12]. [6 p].

37. An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
    December 01, 2011 - On a Medicare allowable cost comparison basis, a full course of CyberKnife SBRT costs considerably … Two additional cost analyses to consider are: Corcoran AT, Peele PB, Benoit RM. … Cost comparison between watchful waiting with active surveillance and active treatment of clinically … analysis of prostate cancer treatments, and the misconceptions regarding the costs of proton therapy … Any cost comparisons and economic evaluations should either (i) not be included in the Final Report

38. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - Ivacaftor costs about $294,000 per year, and some financial analysts expect that third-party payers … Additionally, the manufacturer is expected to implement stratified pricing terms based on patient insurance … patients aged 6 years and older who have a G551D mutation in the CFTR gene. 8 Ivacaftor’s annual pricing … was set at about $294,000. 9 The manufacturer has implemented stratified pricing terms based on patient … insurance status and income. 10 While ivacaftor’s annual price is high, pricing was purported to

39. Nutrition as Prevention for Improved Cancer Health Outcomes | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/improved-cancer-outcomes/research
    May 01, 2024 - , cost-benefit) or provided costs detailed by intervention component; generally, these studies reported … only overall costs from inpatient non-U.S. settings. … We conducted grey literature searches to identify additional resources relevant to the associated costs … or value (e.g., cost-effectiveness, cost-benefit) of nutrition interventions. … ., cost-effectiveness, cost-benefit) information related to the intervention.

40. Obesity (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - The cost of liraglutide at the dosage used to treat obesity is expected to be greater than the cost … drug pricing resource GoodRX lists pricing for 30-day supplies ranging from $149.99 to $159.99 at various … As of June 2013, the online U.S. drug pricing resource GoodRX listed pricing for 30-day supplies ranging … can afford the cost. … Qsymia pricing. [internet]. Santa Monica (CA): GoodRx, Inc.; 2012 Nov [accessed 2012 Nov 6].